Outcome measures for research in treatment of adult males with symptoms of lower urinary tract dysfunction

Neurourology and Urodynamics

Volumn 17, Issue 3, 1998, Pages 263-271

  Nordling, J ^a,b   Abrams, P ^b   Ameda, K ^b   Andersen, J T ^b   Donovan, J ^b   Griffiths, D ^b   Kobayashi, S ^b   Koyanagi, T ^b   Schafer W ^b   Yalla, S ^b   Mattiasson, A ^b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b ICS Male Outcome Subcommittee ^*

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER NECK STENOSIS; HUMAN; MALE; OUTCOMES RESEARCH; PROSTATE HYPERTROPHY; QUALITY OF LIFE; REVIEW; SYMPTOMATOLOGY; URETHRA; URINARY TRACT FUNCTION; URINARY TRACT OBSTRUCTION;

ADULT; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PROSTATE; QUALITY OF LIFE; UROLOGIC DISEASES;

EID: 7144255514     PISSN: 07332467     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6777(1998)17:3<263::AID-NAU11>3.0.CO;2-L     Document Type: Review

References (36)

1. Abrams PH, Griffiths DJ (1979): The assessment of prostatic obstruction from urodynamic measurements and from residual urine. Br J Urol 51:129-134.
2. Andersen JT, Nordling J (1980): Prostatism II. The correlation between cystourethroscopic, cystometric and urodynamic findings. Scand J Urol Nephrol 14:23-27.
3. Bangma CH, Qais A, Niemer HJ, Grobbee DE, Schröder FH (1996): Transrectal ultrasonic volumetry of the prostate: In vivo comparison of different methods. Prostate 28:107-110.
4. Barry MJ, Fowler FJ, O'Leary MP, et al. (1992): The American Urological Association Symptom Index for Benign Prostatic Hyperplasia. J Urol 148:1549-1557.
5. Barry MJ, Fowler FJ, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK (1995): Measuring disease-specific health status in men with benign prostatic hyperplasia. Med Care 334:145-155.
6. Bødker A, Lendorf A, Holm-Nielsen A, Glahn B (1989): Micturation pattern assessed by the frequency/ volume chart in a healthy population of men and women. Neurourol Urodyn 8:421-422.
7. Bolognese JA, Kozloff RC, Kumitz SC, Grino PB, Patrick DL, Stoner E (1992): Validation of a symptoms questionnaire for benign prostatic hyperplasia. Prostate 21:247-254.
8. Bosch JL, AR, Hop WCJ, Niemer QHJ, Bangma CH, Kirkels WJ, Schröder FH (1994): Parameters of prostate volume and shape in a community based population of men 55 to 74 years old. J Urol 152:1501-1505.
9. Boyarsky S, Jones G, Paulson DF, Prout GR (1977): New look at bladder neck obstruction by the Food and Drug Administration regulators. Am Assoc Genitourin Surg 68:29-32.
10. Bruskewitz RC, Iversen P, Madsen PO (1982): Volume of postvoid residual urine determination in evaluation of prostatism. Urology 20:602-604.
11. Cockett ATK, Khoury S, Aso Y, et al. (eds) (1991): "Proceedings of the First International Consultation on Benign Prostatic Hyperplasia" Jersey: Scientific Communications International, Ltd.
12. Cockett ATK, Khoury S, Aso Y, et al. (eds) (1996): "Proceedings of the Third International Consultation on Benign Prostatic Hyperplasia." Jersey: Scientific Communications International, Ltd.
13. Diokno AC, Brown MR, Goldstein NC, Herzog AR (1994): Urinary flow rates and voiding pressures in elderly men living in a community. J Urol 151:1550-1553.
14. Donovan JL, Abrams P, Peters TY, Kay HE, Reynard J, Chapple C, de la Rosette JJCH, Kondo A (1996): The ICS "BPH" study. The psychometric validity and reliability of the ICSmale questionnaire. Br J Urol 77:554-562
15. Donovan JL, Kay HE, Peters TJ, Abrams P, Coast J, Matos-Ferreira A, Rentzhog L, Bosch JLHR, Nordling J, Gajewski JB, Barbalias G, Schick E, Mendes Silva M, Nissenkorn I, De la Rosette JJMCH (1997): Using the ICSQoL to measure the impact of lower urinary tract symptoms on quality of life: Evidence from the ICS-"BPH" study. Br J Urol 80:712-721.
16. Dunsmuir WD, Feneley M, Corry DA, Bryan J, Kirby JS (1996): The day-to-day variation (test-retest reliability) of residual urine measurement. Br J Urol 77:192-193.
17. Fowler FJ Jr, Wennberg JE, Timothy RP, Barry MJ, Mulley AG Jr, Hanley D (1988): Symptom status and quality of life following prostatectomy. JAMA 259:3018-3022.
18. Girman CJ, Epstein RS, Jacobsen SJ, Guess HA, Panser LA, Oesterling JE, Lieber MM (1994): Natural history of prostatism: Impact of urinary symptoms on quality of life in 2115 randomly selected community men. Urology 44:825-831.
19. Griffiths D, Höfner K, van Mastrigt R, Rollema HJ, Spångberg A, Gleason D (1997): Standardization of terminology of lower urinary tract function: Pressure-flow studies of voiding, urethral resistance, and urethral obstruction. Neurourol Urodyn 16:1-18.
20. Grino PB, Bruskewitz R, Blaivas JG, Siroky MB, Andersen JT, Cook T, Stoner E (1993): Maximum urinary flow rate by uroflowmetry: Automatic or visual interpretation. J Urol 149:339-341.
21. Hald T, Nordling J, Andersen JT, Bilde T, Meyhoff HH, Walter S (1991): A patient weighted symptom score system in the evaluation of uncomplicated benign prostatic hyperpiasia. Scand J Urol Nephrol [Suppl] 138:59-62.
22. Hansen B, Flyger H, Brasso K, Schou J, Nordling J, Andersen JT, Mortensen S, Meyhoff HH, Walter S, Hald T (1995): Validation of the self-administered Danish Prostatic Symptom Score (DAN-PSS-1) system for use in benign prostatic hyperpiasia. Br J Urol 76:451-458.
23. Hastak SM, Gammelgaard J, Holm HH (1982): Transrectal ultrasonic volume determination of the prostate - A preoperative and postoperative study. J Urol 127:1115-1118.
24. Hendriks AJ, Wijkstra H, Maes RM, et al. (1991): Audex Medical, a new system for digital processing and analysis of ultrasonographic images of the prostate. Scand J Urol Nephrol [Suppl] 137:95-100.
25. Jones DR, Roberts EE, Griffiths GJ, et al. (1989): Assessment of volume measurement of the prostate using per-rectal ultrasonography. Br J Urol 64:493-495.
26. Keoghane SR, Lawrence KC, Gray AM, Chappel DB, Hancock AM, Cranston DW (1996): The Oxford laser prostate trial: Economic issues surrounding contact laser prostatectomy. Br J Urol 77:386-390.
27. Lukacs B, McCarthy C, Lepleqe A, Comet D (1994): Development and validation of a quality of life scale associated with health status, specific for benign hypertrophy of the prostate and including a sexuality evaluation scale. Prog Urol 4:688-699.
28. Madsen PO, Iversen P (1983): A point system for selecting operative candidates. In Hinmann F (ed): "Benign Prostatic Hypertrophy." New York: Springer-Verlag, pp 763-765.
29. Marks LSM, Treiger B, Dorey FJ, Fu YS, Dekernion JB (1994): Morphometry of the prostata: I. Distribution of tissue components in hyperpiasia glands. Urology 44:486-492.
30. Nathan MS, Seemivasagam K, Mei Q, Wickham JEA, Miller RA (1996): Transrectal ultrasonography: Why are estimates of prostate volume and dimension so inaccurate? Br J Urol 77:401-407.
31. Neal DE, Styles RA, Powell PH, Ramsden PD (1987): Relationship between detrusor function and residual urine in men undergoing prostatectomy. Br J Urol 60:560-566.
32. O'Leary MP, Fowler FJ, Lenderking WR, Barber B, Sagnier PP, Guess HA, Barry MJ (1995): A brief male sexual function inventory for urology. Urology 46:697-706.
33. Peeling WB (1989): Diagnostic assessment of benign prostatic hyperpiasia. Prostata 114:52-68.
34. Poulsen AL, Schou J, Puggaard L, Torp-Pedersen S, Nordling J (1994): Prostatic enlargement, symptomatology and pressure-flow evaluation: Interrelations in patients with symptomatic BPH. Scand J Urol Nephrol [Suppl] 157:67-73.
35. Rosier PFVVM, de Wildt MJAM, Wijkstra H, Debruyne FFMJ, de la Rosette JMCH (1996): Clinical diagnosis of bladder outlet obstruction in patients with benign prostatic enlargement and lower urinary tract symptoms: Development and urodynamic validation of a clinical prostate score for the objective diagnosis of bladder outlet obstruction. J Urol 155:1649-1654.
36. Terris MK, Stamey TA (1991): Determination of prostate volume by transrectal ultrasound. J Urol 145:984-987.